CARB-X announced today that it is awarding up to $2.5 million to GangaGen Biotechnologies of Bangalore, India, to develop novel antibacterial proteins to treat hospital-acquired and ventilator-associated pneumonia caused by Klebsiella pneumoniae.
Some experts say that offering a manual for re-creating an orthopoxvirus is inherently dangerous.
Scientists with the US Centers for Disease Control and Prevention (CDC) have detected a new orthopoxvirus—the family of viruses that includes smallpox and cowpox—in three people in the nation of Georgia, including two herdsmen, the CDC reported in a news release yesterday.
